Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p34
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 34/191)
Character Range: 9845935–9859096

the patient's medical records at the time pramipexole treatment is initiated.
                                                                                                                                                                                                                               The diagnostic criteria for Restless Legs Syndrome are
                                                                                                                                                                                                                               (a) An urge to move the legs usually accompanied or caused by unpleasant sensations in the legs; and
                                                                                                                                                                                                                               (b) The urge to move or unpleasant sensations begin or worsen during periods of rest or inactivity such as lying or sitting; and
                                                                                                                                                                                                                               (c) The urge to move or unpleasant sensations are partially or totally relieved by movement, such as walking or stretching, at least as long as the activity continues; and
                                                                                                                                                                                                                               (d) The urge to move or unpleasant sensations are worse in the evening or night than during the day or only occur during the evening or night.
C5412               P5412          CN5412           Desmopressin                                                                                                                                                               Primary nocturnal enuresis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Compliance with Authority Required procedures - Streamlined Authority Code 5412
                                                                                                                                                                                                                               Patient must be 6 years of age or older;
                                                                                                                                                                                                                               Patient must be refractory to an enuresis alarm.
C5413               P5413          CN5413           Desmopressin                                                                                                                                                               Primary nocturnal enuresis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Compliance with Authority Required procedures - Streamlined Authority Code 5413
                                                                                                                                                                                                                               Patient must be 6 years of age or older;
                                                                                                                                                                                                                               Patient must be refractory to an enuresis alarm.
C5414               P5414          CN5414           Flucloxacillin                                                                                                                                                             Serious staphylococcal infection

C5415               P5415          CN5415           Dicloxacillin                                                                                                                                                              Serious staphylococcal infection

C5437               P5437          CN5437           Goserelin                                                                                                                                                                  Breast cancer
                                                                                                                                                                                                                               The condition must be hormone receptor positive.
C5444               P5444          CN5444           Lansoprazole                                                                                                                                                               Gastro-oesophageal reflux disease

                                                    Omeprazole

                                                    Pantoprazole

                                                    Rabeprazole

C5446               P5446          CN5446           Tobramycin                                                                                                                                                                 Septicaemia, suspected

C5450               P5450          CN5450           Anakinra                                                                                                                                                                   Moderate to severe cryopyrin associated periodic syndromes (CAPS)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Compliance with Authority Required procedures - Streamlined Authority Code 5450
                                                                                                                                                                                                                               Must be treated by a rheumatologist or in consultation with a rheumatologist.  or
                                                                                                                                                                                                                               Must be treated by a clinical immunologist or in consultation with a clinical immunologist.
                                                                                                                                                                                                                               A diagnosis of CAPS must be documented in the patient's medical records.
C5451               P5451          CN5451           Tobramycin                                                                                                                                                                 Perioperative use in ophthalmic surgery

C5452               P5452          CN5452           Panitumumab                                                                                                                                                                Metastatic colorectal cancer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 5452
                                                                                                                                                                                                                               Continuing treatment
                                                                                                                                                                                                                               Patient must have received an initial authority prescription for panitumumab for first-line treatment of RAS wild-type metastatic colorectal cancer; AND
                                                                                                                                                                                                                               Patient must not have progressive disease; AND
                                                                                                                                                                                                                               The treatment must be in combination with first-line chemotherapy; AND
                                                                                                                                                                                                                               The treatment must be the sole PBS-subsidised anti-EGFR antibody therapy for this condition.
                                                                                                                                                                                                                               Patients who have progressive disease on cetuximab are not eligible to receive PBS-subsidised panitumumab.
                                                                                                                                                                                                                               Patients who have developed intolerance to cetuximab of a severity necessitating permanent treatment withdrawal are eligible to receive PBS-subsidised panitumumab.
C5461               P5461          CN5461           Clobetasol                                                                                                                                                                 Moderate to severe scalp psoriasis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Compliance with Authority Required procedures - Streamlined Authority Code 5461
                                                                                                                                                                                                                               The condition must be inadequately controlled with either a vitamin D analogue or potent topical corticosteroid as monotherapy; or
                                                                                                                                                                                                                               The condition must be inadequately controlled with combination use of a vitamin